HealthdirectFree Australian health advice you can count on.

( ARTG ) Keppra (film coated tablets and oral solution) is indicated for - Use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation, - Monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy.‍‍‍‍‍‍​​​‍​​​​​​ - Add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME), and - Add on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (IGE). Keppra concentrate solution for IV infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.